Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Oral Solid Dosage Pharmaceutical Formulation Sales Market Report 2017

  • QYR2286884
  • 112 Pages
  • December 2017
  • Pharmaceuticals
Download Sample    Get Discount   
 
In this report, the global Oral Solid Dosage Pharmaceutical Formulation market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Oral Solid Dosage Pharmaceutical Formulation for these regions, from 2012 to 2022 (forecast), covering

United States

China

Europe

Japan

Southeast Asia

India

Global Oral Solid Dosage Pharmaceutical Formulation market competition by top manufacturers/players, with Oral Solid Dosage Pharmaceutical Formulation sales volume, Price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including

AstraZeneca Plc.

Bristol-Myers Squibb Company

Eli Lilly and Company

Gilead Sciences

Merck & Co. Inc.

Novartis AG

Pfizer Inc.

AbbVie Inc.

Boehringer Ingelheim GmbH

Hoffman-La-Roche Ltd.

Johnson & Johnson

Biogen Inc.

Bayer AG

Teva Pharmaceticals

Amgen Inc.

Takeda Pharmaceutical Company Ltd.

Otsuka Pharmaceutical Co., Ltd.

Shire Plc.

Celgene Corporation

Astellas Pharma Inc.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

By Form

Capsules

Powders

Tablets

By Drug Release Mechanism

Immediate Release

Extended Release

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

Hospitals

Clinics

Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

Global Oral Solid Dosage Pharmaceutical Formulation Sales Market Report 2017

1 Oral Solid Dosage Pharmaceutical Formulation Market Overview

1.1 Product Overview and Scope of Oral Solid Dosage Pharmaceutical Formulation

1.2 Classification of Oral Solid Dosage Pharmaceutical Formulation by Product Category

1.2.1 Global Oral Solid Dosage Pharmaceutical Formulation Market Size (Sales) Comparison by Type (2012-2022)

1.2.2 Global Oral Solid Dosage Pharmaceutical Formulation Market Size (Sales) Market Share by Type (Product Category) in 2016

1.2.3 Capsules

1.2.4 Powders

1.2.5 Tablets

1.3 Global Oral Solid Dosage Pharmaceutical Formulation Market by Application/End Users

1.3.1 Global Oral Solid Dosage Pharmaceutical Formulation Sales (Volume) and Market Share Comparison by Application (2012-2022)

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Other

1.4 Global Oral Solid Dosage Pharmaceutical Formulation Market by Region

1.4.1 Global Oral Solid Dosage Pharmaceutical Formulation Market Size (Value) Comparison by Region (2012-2022)

1.4.2 United States Oral Solid Dosage Pharmaceutical Formulation Status and Prospect (2012-2022)

1.4.3 China Oral Solid Dosage Pharmaceutical Formulation Status and Prospect (2012-2022)

1.4.4 Europe Oral Solid Dosage Pharmaceutical Formulation Status and Prospect (2012-2022)

1.4.5 Japan Oral Solid Dosage Pharmaceutical Formulation Status and Prospect (2012-2022)

1.4.6 Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Status and Prospect (2012-2022)

1.4.7 India Oral Solid Dosage Pharmaceutical Formulation Status and Prospect (2012-2022)

1.5 Global Market Size (Value and Volume) of Oral Solid Dosage Pharmaceutical Formulation (2012-2022)

1.5.1 Global Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2012-2022)

1.5.2 Global Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate (2012-2022)

2 Global Oral Solid Dosage Pharmaceutical Formulation Competition by Players/Suppliers, Type and Application

2.1 Global Oral Solid Dosage Pharmaceutical Formulation Market Competition by Players/Suppliers

2.1.1 Global Oral Solid Dosage Pharmaceutical Formulation Sales and Market Share of Key Players/Suppliers (2012-2017)

2.1.2 Global Oral Solid Dosage Pharmaceutical Formulation Revenue and Share by Players/Suppliers (2012-2017)

2.2 Global Oral Solid Dosage Pharmaceutical Formulation (Volume and Value) by Type

2.2.1 Global Oral Solid Dosage Pharmaceutical Formulation Sales and Market Share by Type (2012-2017)

2.2.2 Global Oral Solid Dosage Pharmaceutical Formulation Revenue and Market Share by Type (2012-2017)

2.3 Global Oral Solid Dosage Pharmaceutical Formulation (Volume and Value) by Region

2.3.1 Global Oral Solid Dosage Pharmaceutical Formulation Sales and Market Share by Region (2012-2017)

2.3.2 Global Oral Solid Dosage Pharmaceutical Formulation Revenue and Market Share by Region (2012-2017)

2.4 Global Oral Solid Dosage Pharmaceutical Formulation (Volume) by Application

3 United States Oral Solid Dosage Pharmaceutical Formulation (Volume, Value and Sales Price)

3.1 United States Oral Solid Dosage Pharmaceutical Formulation Sales and Value (2012-2017)

3.1.1 United States Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2012-2017)

3.1.2 United States Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate (2012-2017)

3.1.3 United States Oral Solid Dosage Pharmaceutical Formulation Sales Price Trend (2012-2017)

3.2 United States Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Market Share by Players

3.3 United States Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Market Share by Type

3.4 United States Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Market Share by Application

4 China Oral Solid Dosage Pharmaceutical Formulation (Volume, Value and Sales Price)

4.1 China Oral Solid Dosage Pharmaceutical Formulation Sales and Value (2012-2017)

4.1.1 China Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2012-2017)

4.1.2 China Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate (2012-2017)

4.1.3 China Oral Solid Dosage Pharmaceutical Formulation Sales Price Trend (2012-2017)

4.2 China Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Market Share by Players

4.3 China Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Market Share by Type

4.4 China Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Market Share by Application

5 Europe Oral Solid Dosage Pharmaceutical Formulation (Volume, Value and Sales Price)

5.1 Europe Oral Solid Dosage Pharmaceutical Formulation Sales and Value (2012-2017)

5.1.1 Europe Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2012-2017)

5.1.2 Europe Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate (2012-2017)

5.1.3 Europe Oral Solid Dosage Pharmaceutical Formulation Sales Price Trend (2012-2017)

5.2 Europe Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Market Share by Players

5.3 Europe Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Market Share by Type

5.4 Europe Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Market Share by Application

6 Japan Oral Solid Dosage Pharmaceutical Formulation (Volume, Value and Sales Price)

6.1 Japan Oral Solid Dosage Pharmaceutical Formulation Sales and Value (2012-2017)

6.1.1 Japan Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2012-2017)

6.1.2 Japan Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate (2012-2017)

6.1.3 Japan Oral Solid Dosage Pharmaceutical Formulation Sales Price Trend (2012-2017)

6.2 Japan Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Market Share by Players

6.3 Japan Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Market Share by Type

6.4 Japan Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Market Share by Application

7 Southeast Asia Oral Solid Dosage Pharmaceutical Formulation (Volume, Value and Sales Price)

7.1 Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Sales and Value (2012-2017)

7.1.1 Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2012-2017)

7.1.2 Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate (2012-2017)

7.1.3 Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Sales Price Trend (2012-2017)

7.2 Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Market Share by Players

7.3 Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Market Share by Type

7.4 Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Market Share by Application

8 India Oral Solid Dosage Pharmaceutical Formulation (Volume, Value and Sales Price)

8.1 India Oral Solid Dosage Pharmaceutical Formulation Sales and Value (2012-2017)

8.1.1 India Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2012-2017)

8.1.2 India Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate (2012-2017)

8.1.3 India Oral Solid Dosage Pharmaceutical Formulation Sales Price Trend (2012-2017)

8.2 India Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Market Share by Players

8.3 India Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Market Share by Type

8.4 India Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Market Share by Application

9 Global Oral Solid Dosage Pharmaceutical Formulation Players/Suppliers Profiles and Sales Data

9.1 AstraZeneca Plc.

9.1.1 Company Basic Information, Manufacturing Base and Competitors

9.1.2 Oral Solid Dosage Pharmaceutical Formulation Product Category, Application and Specification

9.1.2.1 Product A

9.1.2.2 Product B

9.1.3 AstraZeneca Plc. Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin (2012-2017)

9.1.4 Main Business/Business Overview

9.2 Bristol-Myers Squibb Company

9.2.1 Company Basic Information, Manufacturing Base and Competitors

9.2.2 Oral Solid Dosage Pharmaceutical Formulation Product Category, Application and Specification

9.2.2.1 Product A

9.2.2.2 Product B

9.2.3 Bristol-Myers Squibb Company Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin (2012-2017)

9.2.4 Main Business/Business Overview

9.3 Eli Lilly and Company

9.3.1 Company Basic Information, Manufacturing Base and Competitors

9.3.2 Oral Solid Dosage Pharmaceutical Formulation Product Category, Application and Specification

9.3.2.1 Product A

9.3.2.2 Product B

9.3.3 Eli Lilly and Company Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin (2012-2017)

9.3.4 Main Business/Business Overview

9.4 Gilead Sciences

9.4.1 Company Basic Information, Manufacturing Base and Competitors

9.4.2 Oral Solid Dosage Pharmaceutical Formulation Product Category, Application and Specification

9.4.2.1 Product A

9.4.2.2 Product B

9.4.3 Gilead Sciences Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin (2012-2017)

9.4.4 Main Business/Business Overview

9.5 Merck & Co. Inc.

9.5.1 Company Basic Information, Manufacturing Base and Competitors

9.5.2 Oral Solid Dosage Pharmaceutical Formulation Product Category, Application and Specification

9.5.2.1 Product A

9.5.2.2 Product B

9.5.3 Merck & Co. Inc. Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin (2012-2017)

9.5.4 Main Business/Business Overview

9.6 Novartis AG

9.6.1 Company Basic Information, Manufacturing Base and Competitors

9.6.2 Oral Solid Dosage Pharmaceutical Formulation Product Category, Application and Specification

9.6.2.1 Product A

9.6.2.2 Product B

9.6.3 Novartis AG Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin (2012-2017)

9.6.4 Main Business/Business Overview

9.7 Pfizer Inc.

9.7.1 Company Basic Information, Manufacturing Base and Competitors

9.7.2 Oral Solid Dosage Pharmaceutical Formulation Product Category, Application and Specification

9.7.2.1 Product A

9.7.2.2 Product B

9.7.3 Pfizer Inc. Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin (2012-2017)

9.7.4 Main Business/Business Overview

9.8 AbbVie Inc.

9.8.1 Company Basic Information, Manufacturing Base and Competitors

9.8.2 Oral Solid Dosage Pharmaceutical Formulation Product Category, Application and Specification

9.8.2.1 Product A

9.8.2.2 Product B

9.8.3 AbbVie Inc. Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin (2012-2017)

9.8.4 Main Business/Business Overview

9.9 Boehringer Ingelheim GmbH

9.9.1 Company Basic Information, Manufacturing Base and Competitors

9.9.2 Oral Solid Dosage Pharmaceutical Formulation Product Category, Application and Specification

9.9.2.1 Product A

9.9.2.2 Product B

9.9.3 Boehringer Ingelheim GmbH Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin (2012-2017)

9.9.4 Main Business/Business Overview

9.10 Hoffman-La-Roche Ltd.

9.10.1 Company Basic Information, Manufacturing Base and Competitors

9.10.2 Oral Solid Dosage Pharmaceutical Formulation Product Category, Application and Specification

9.10.2.1 Product A

9.10.2.2 Product B

9.10.3 Hoffman-La-Roche Ltd. Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin (2012-2017)

9.10.4 Main Business/Business Overview

9.11 Johnson & Johnson

9.12 Biogen Inc.

9.13 Bayer AG

9.14 Teva Pharmaceticals

9.15 Amgen Inc.

9.16 Takeda Pharmaceutical Company Ltd.

9.17 Otsuka Pharmaceutical Co., Ltd.

9.18 Shire Plc.

9.19 Celgene Corporation

9.20 Astellas Pharma Inc.

10 Oral Solid Dosage Pharmaceutical Formulation Maufacturing Cost Analysis

10.1 Oral Solid Dosage Pharmaceutical Formulation Key Raw Materials Analysis

10.1.1 Key Raw Materials

10.1.2 Price Trend of Key Raw Materials

10.1.3 Key Suppliers of Raw Materials

10.1.4 Market Concentration Rate of Raw Materials

10.2 Proportion of Manufacturing Cost Structure

10.2.1 Raw Materials

10.2.2 Labor Cost

10.2.3 Manufacturing Process Analysis of Oral Solid Dosage Pharmaceutical Formulation

10.3 Manufacturing Process Analysis of Oral Solid Dosage Pharmaceutical Formulation

11 Industrial Chain, Sourcing Strategy and Downstream Buyers

11.1 Oral Solid Dosage Pharmaceutical Formulation Industrial Chain Analysis

11.2 Upstream Raw Materials Sourcing

11.3 Raw Materials Sources of Oral Solid Dosage Pharmaceutical Formulation Major Manufacturers in 2016

11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders

12.1 Marketing Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.1.3 Marketing Channel Development Trend

12.2 Market Positioning

12.2.1 Pricing Strategy

12.2.2 Brand Strategy

12.2.3 Target Client

12.3 Distributors/Traders List

13 Market Effect Factors Analysis

13.1 Technology Progress/Risk

13.1.1 Substitutes Threat

13.1.2 Technology Progress in Related Industry

13.2 Consumer Needs/Customer Preference Change

13.3 Economic/Political Environmental Change

14 Global Oral Solid Dosage Pharmaceutical Formulation Market Forecast (2017-2022)

14.1 Global Oral Solid Dosage Pharmaceutical Formulation Sales Volume, Revenue and Price Forecast (2017-2022)

14.1.1 Global Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Growth Rate Forecast (2017-2022)

14.1.2 Global Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate Forecast (2017-2022)

14.1.3 Global Oral Solid Dosage Pharmaceutical Formulation Price and Trend Forecast (2017-2022)

14.2 Global Oral Solid Dosage Pharmaceutical Formulation Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)

14.2.1 Global Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Growth Rate Forecast by Regions (2017-2022)

14.2.2 Global Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate Forecast by Regions (2017-2022)

14.2.3 United States Oral Solid Dosage Pharmaceutical Formulation Sales Volume, Revenue and Growth Rate Forecast (2017-2022)

14.2.4 China Oral Solid Dosage Pharmaceutical Formulation Sales Volume, Revenue and Growth Rate Forecast (2017-2022)

14.2.5 Europe Oral Solid Dosage Pharmaceutical Formulation Sales Volume, Revenue and Growth Rate Forecast (2017-2022)

14.2.6 Japan Oral Solid Dosage Pharmaceutical Formulation Sales Volume, Revenue and Growth Rate Forecast (2017-2022)

14.2.7 Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Sales Volume, Revenue and Growth Rate Forecast (2017-2022)

14.2.8 India Oral Solid Dosage Pharmaceutical Formulation Sales Volume, Revenue and Growth Rate Forecast (2017-2022)

14.3 Global Oral Solid Dosage Pharmaceutical Formulation Sales Volume, Revenue and Price Forecast by Type (2017-2022)

14.3.1 Global Oral Solid Dosage Pharmaceutical Formulation Sales Forecast by Type (2017-2022)

14.3.2 Global Oral Solid Dosage Pharmaceutical Formulation Revenue Forecast by Type (2017-2022)

14.3.3 Global Oral Solid Dosage Pharmaceutical Formulation Price Forecast by Type (2017-2022)

14.4 Global Oral Solid Dosage Pharmaceutical Formulation Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology/Research Approach

16.1.1 Research Programs/Design

16.1.2 Market Size Estimation

16.1.3 Market Breakdown and Data Triangulation

16.2 Data Source

16.2.1 Secondary Sources

16.2.2 Primary Sources

16.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Oral Solid Dosage Pharmaceutical Formulation

Figure Global Oral Solid Dosage Pharmaceutical Formulation Sales Volume Comparison (K MT) by Type (2012-2022)

Figure Global Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Type (Product Category) in 2016

Figure Capsules Product Picture

Figure Powders Product Picture

Figure Tablets Product Picture

Figure Global Oral Solid Dosage Pharmaceutical Formulation Sales Comparison (K MT) by Application (2012-2022)

Figure Global Sales Market Share of Oral Solid Dosage Pharmaceutical Formulation by Application in 2016

Figure Hospitals Examples

Table Key Downstream Customer in Hospitals

Figure Clinics Examples

Table Key Downstream Customer in Clinics

Figure Other Examples

Table Key Downstream Customer in Other

Figure Global Oral Solid Dosage Pharmaceutical Formulation Market Size (Million USD) by Regions (2012-2022)

Figure United States Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Growth Rate (2012-2022)

Figure China Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Growth Rate (2012-2022)

Figure Europe Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Growth Rate (2012-2022)

Figure Japan Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Growth Rate (2012-2022)

Figure India Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Growth Rate (2012-2022)

Figure Global Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) and Growth Rate (2012-2022)

Figure Global Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Growth Rate (2012-2022)

Figure Global Market Major Players Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) (2012-2017)

Table Global Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) of Key Players/Suppliers (2012-2017)

Table Global Oral Solid Dosage Pharmaceutical Formulation Sales Share by Players/Suppliers (2012-2017)

Figure 2016 Oral Solid Dosage Pharmaceutical Formulation Sales Share by Players/Suppliers

Figure 2017 Oral Solid Dosage Pharmaceutical Formulation Sales Share by Players/Suppliers

Figure Global Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) by Players/Suppliers (2012-2017)

Table Global Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) by Players/Suppliers (2012-2017)

Table Global Oral Solid Dosage Pharmaceutical Formulation Revenue Share by Players/Suppliers (2012-2017)

Table 2016 Global Oral Solid Dosage Pharmaceutical Formulation Revenue Share by Players

Table 2017 Global Oral Solid Dosage Pharmaceutical Formulation Revenue Share by Players

Table Global Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Market Share by Type (2012-2017)

Table Global Oral Solid Dosage Pharmaceutical Formulation Sales Share (K MT) by Type (2012-2017)

Figure Sales Market Share of Oral Solid Dosage Pharmaceutical Formulation by Type (2012-2017)

Figure Global Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate by Type (2012-2017)

Table Global Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Market Share by Type (2012-2017)

Table Global Oral Solid Dosage Pharmaceutical Formulation Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Oral Solid Dosage Pharmaceutical Formulation by Type (2012-2017)

Figure Global Oral Solid Dosage Pharmaceutical Formulation Revenue Growth Rate by Type (2012-2017)

Table Global Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) and Market Share by Region (2012-2017)

Table Global Oral Solid Dosage Pharmaceutical Formulation Sales Share by Region (2012-2017)

Figure Sales Market Share of Oral Solid Dosage Pharmaceutical Formulation by Region (2012-2017)

Figure Global Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate by Region in 2016

Table Global Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Market Share by Region (2012-2017)

Table Global Oral Solid Dosage Pharmaceutical Formulation Revenue Share (%) by Region (2012-2017)

Figure Revenue Market Share of Oral Solid Dosage Pharmaceutical Formulation by Region (2012-2017)

Figure Global Oral Solid Dosage Pharmaceutical Formulation Revenue Growth Rate by Region in 2016

Table Global Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Market Share by Region (2012-2017)

Table Global Oral Solid Dosage Pharmaceutical Formulation Revenue Share (%) by Region (2012-2017)

Figure Revenue Market Share of Oral Solid Dosage Pharmaceutical Formulation by Region (2012-2017)

Figure Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Region in 2016

Table Global Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) and Market Share by Application (2012-2017)

Table Global Oral Solid Dosage Pharmaceutical Formulation Sales Share (%) by Application (2012-2017)

Figure Sales Market Share of Oral Solid Dosage Pharmaceutical Formulation by Application (2012-2017)

Figure Global Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Application (2012-2017)

Figure United States Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate (2012-2017)

Figure United States Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Growth Rate (2012-2017)

Figure United States Oral Solid Dosage Pharmaceutical Formulation Sales Price (USD/MT) Trend (2012-2017)

Table United States Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) by Players (2012-2017)

Table United States Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Players (2012-2017)

Figure United States Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Players in 2016

Table United States Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) by Type (2012-2017)

Table United States Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Type (2012-2017)

Figure United States Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Type in 2016

Table United States Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) by Application (2012-2017)

Table United States Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Application (2012-2017)

Figure United States Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Application in 2016

Figure China Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate (2012-2017)

Figure China Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Growth Rate (2012-2017)

Figure China Oral Solid Dosage Pharmaceutical Formulation Sales Price (USD/MT) Trend (2012-2017)

Table China Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) by Players (2012-2017)

Table China Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Players (2012-2017)

Figure China Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Players in 2016

Table China Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) by Type (2012-2017)

Table China Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Type (2012-2017)

Figure China Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Type in 2016

Table China Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) by Application (2012-2017)

Table China Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Application (2012-2017)

Figure China Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Application in 2016

Figure Europe Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate (2012-2017)

Figure Europe Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Growth Rate (2012-2017)

Figure Europe Oral Solid Dosage Pharmaceutical Formulation Sales Price (USD/MT) Trend (2012-2017)

Table Europe Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) by Players (2012-2017)

Table Europe Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Players (2012-2017)

Figure Europe Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Players in 2016

Table Europe Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) by Type (2012-2017)

Table Europe Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Type (2012-2017)

Figure Europe Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Type in 2016

Table Europe Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) by Application (2012-2017)

Table Europe Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Application (2012-2017)

Figure Europe Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Application in 2016

Figure Japan Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate (2012-2017)

Figure Japan Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Growth Rate (2012-2017)

Figure Japan Oral Solid Dosage Pharmaceutical Formulation Sales Price (USD/MT) Trend (2012-2017)

Table Japan Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) by Players (2012-2017)

Table Japan Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Players (2012-2017)

Figure Japan Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Players in 2016

Table Japan Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) by Type (2012-2017)

Table Japan Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Type (2012-2017)

Figure Japan Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Type in 2016

Table Japan Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) by Application (2012-2017)

Table Japan Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Application (2012-2017)

Figure Japan Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Application in 2016

Figure Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate (2012-2017)

Figure Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Growth Rate (2012-2017)

Figure Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Sales Price (USD/MT) Trend (2012-2017)

Table Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) by Players (2012-2017)

Table Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Players (2012-2017)

Figure Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Players in 2016

Table Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) by Type (2012-2017)

Table Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Type (2012-2017)

Figure Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Type in 2016

Table Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) by Application (2012-2017)

Table Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Application (2012-2017)

Figure Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Application in 2016

Figure India Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate (2012-2017)

Figure India Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Growth Rate (2012-2017)

Figure India Oral Solid Dosage Pharmaceutical Formulation Sales Price (USD/MT) Trend (2012-2017)

Table India Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) by Players (2012-2017)

Table India Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Players (2012-2017)

Figure India Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Players in 2016

Table India Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) by Type (2012-2017)

Table India Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Type (2012-2017)

Figure India Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Type in 2016

Table India Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) by Application (2012-2017)

Table India Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Application (2012-2017)

Figure India Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Application in 2016

Table AstraZeneca Plc. Basic Information List

Table AstraZeneca Plc. Oral Solid Dosage Pharmaceutical Formulation Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure AstraZeneca Plc. Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate (2012-2017)

Figure AstraZeneca Plc. Oral Solid Dosage Pharmaceutical Formulation Sales Global Market Share (2012-2017

Figure AstraZeneca Plc. Oral Solid Dosage Pharmaceutical Formulation Revenue Global Market Share (2012-2017)

Table Bristol-Myers Squibb Company Basic Information List

Table Bristol-Myers Squibb Company Oral Solid Dosage Pharmaceutical Formulation Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Bristol-Myers Squibb Company Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate (2012-2017)

Figure Bristol-Myers Squibb Company Oral Solid Dosage Pharmaceutical Formulation Sales Global Market Share (2012-2017

Figure Bristol-Myers Squibb Company Oral Solid Dosage Pharmaceutical Formulation Revenue Global Market Share (2012-2017)

Table Eli Lilly and Company Basic Information List

Table Eli Lilly and Company Oral Solid Dosage Pharmaceutical Formulation Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Eli Lilly and Company Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate (2012-2017)

Figure Eli Lilly and Company Oral Solid Dosage Pharmaceutical Formulation Sales Global Market Share (2012-2017

Figure Eli Lilly and Company Oral Solid Dosage Pharmaceutical Formulation Revenue Global Market Share (2012-2017)

Table Gilead Sciences Basic Information List

Table Gilead Sciences Oral Solid Dosage Pharmaceutical Formulation Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Gilead Sciences Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate (2012-2017)

Figure Gilead Sciences Oral Solid Dosage Pharmaceutical Formulation Sales Global Market Share (2012-2017

Figure Gilead Sciences Oral Solid Dosage Pharmaceutical Formulation Revenue Global Market Share (2012-2017)

Table Merck & Co. Inc. Basic Information List

Table Merck & Co. Inc. Oral Solid Dosage Pharmaceutical Formulation Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Merck & Co. Inc. Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate (2012-2017)

Figure Merck & Co. Inc. Oral Solid Dosage Pharmaceutical Formulation Sales Global Market Share (2012-2017

Figure Merck & Co. Inc. Oral Solid Dosage Pharmaceutical Formulation Revenue Global Market Share (2012-2017)

Table Novartis AG Basic Information List

Table Novartis AG Oral Solid Dosage Pharmaceutical Formulation Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Novartis AG Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate (2012-2017)

Figure Novartis AG Oral Solid Dosage Pharmaceutical Formulation Sales Global Market Share (2012-2017

Figure Novartis AG Oral Solid Dosage Pharmaceutical Formulation Revenue Global Market Share (2012-2017)

Table Pfizer Inc. Basic Information List

Table Pfizer Inc. Oral Solid Dosage Pharmaceutical Formulation Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Pfizer Inc. Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate (2012-2017)

Figure Pfizer Inc. Oral Solid Dosage Pharmaceutical Formulation Sales Global Market Share (2012-2017

Figure Pfizer Inc. Oral Solid Dosage Pharmaceutical Formulation Revenue Global Market Share (2012-2017)

Table AbbVie Inc. Basic Information List

Table AbbVie Inc. Oral Solid Dosage Pharmaceutical Formulation Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure AbbVie Inc. Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate (2012-2017)

Figure AbbVie Inc. Oral Solid Dosage Pharmaceutical Formulation Sales Global Market Share (2012-2017

Figure AbbVie Inc. Oral Solid Dosage Pharmaceutical Formulation Revenue Global Market Share (2012-2017)

Table Boehringer Ingelheim GmbH Basic Information List

Table Boehringer Ingelheim GmbH Oral Solid Dosage Pharmaceutical Formulation Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Boehringer Ingelheim GmbH Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate (2012-2017)

Figure Boehringer Ingelheim GmbH Oral Solid Dosage Pharmaceutical Formulation Sales Global Market Share (2012-2017

Figure Boehringer Ingelheim GmbH Oral Solid Dosage Pharmaceutical Formulation Revenue Global Market Share (2012-2017)

Table Hoffman-La-Roche Ltd. Basic Information List

Table Hoffman-La-Roche Ltd. Oral Solid Dosage Pharmaceutical Formulation Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Hoffman-La-Roche Ltd. Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate (2012-2017)

Figure Hoffman-La-Roche Ltd. Oral Solid Dosage Pharmaceutical Formulation Sales Global Market Share (2012-2017

Figure Hoffman-La-Roche Ltd. Oral Solid Dosage Pharmaceutical Formulation Revenue Global Market Share (2012-2017)

Table Johnson & Johnson Basic Information List

Table Biogen Inc. Basic Information List

Table Bayer AG Basic Information List

Table Teva Pharmaceticals Basic Information List

Table Amgen Inc. Basic Information List

Table Takeda Pharmaceutical Company Ltd. Basic Information List

Table Otsuka Pharmaceutical Co., Ltd. Basic Information List

Table Shire Plc. Basic Information List

Table Celgene Corporation Basic Information List

Table Astellas Pharma Inc. Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Oral Solid Dosage Pharmaceutical Formulation

Figure Manufacturing Process Analysis of Oral Solid Dosage Pharmaceutical Formulation

Figure Oral Solid Dosage Pharmaceutical Formulation Industrial Chain Analysis

Table Raw Materials Sources of Oral Solid Dosage Pharmaceutical Formulation Major Players in 2016

Table Major Buyers of Oral Solid Dosage Pharmaceutical Formulation

Table Distributors/Traders List

Figure Global Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) and Growth Rate Forecast (2017-2022)

Figure Global Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure Global Oral Solid Dosage Pharmaceutical Formulation Price (USD/MT) and Trend Forecast (2017-2022)

Table Global Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) Forecast by Regions (2017-2022)

Figure Global Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share Forecast by Regions (2017-2022)

Figure Global Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share Forecast by Regions in 2022

Table Global Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) Forecast by Regions (2017-2022)

Figure Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share Forecast by Regions (2017-2022)

Figure Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share Forecast by Regions in 2022

Figure United States Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) and Growth Rate Forecast (2017-2022)

Figure United States Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure China Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) and Growth Rate Forecast (2017-2022)

Figure China Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate Forecast (2017-2022)

Figure Europe Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) and Growth Rate Forecast (2017-2022)

Figure Europe Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure Japan Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) and Growth Rate Forecast (2017-2022)

Figure Japan Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) and Growth Rate Forecast (2017-2022)

Figure Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure India Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) and Growth Rate Forecast (2017-2022)

Figure India Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Table Global Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) Forecast by Type (2017-2022)

Figure Global Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share Forecast by Type (2017-2022)

Table Global Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) Forecast by Type (2017-2022)

Figure Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share Forecast by Type (2017-2022)

Table Global Oral Solid Dosage Pharmaceutical Formulation Price (USD/MT) Forecast by Type (2017-2022)

Table Global Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) Forecast by Application (2017-2022)

Figure Global Oral Solid Dosage Pharmaceutical Formulation Sales Market Share Forecast by Application (2017-2022)

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370